1 |
Brachmann J, Ansah M, Kosinski E, et al. Improved clinical effectiveness with collagen vascular hemostasis device for shortened immobilization time following diagnostic angiography and percutaneous transluminal angioplasty. Am J Cardiol 1998;81:1502-5
DOI
PUBMED
ScienceOn
|
2 |
Sanborn TA, Gibbs HH, Brinker JA, et al. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273-9
DOI
ScienceOn
|
3 |
Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated devices. J Vasc Surg 2001;33:688-93
DOI
ScienceOn
|
4 |
Kussmaul WG, Buchbinder M, Whitlow P, et al. Rapid arterial hemostasis after cardiac catheterization and percutaneous transluminal angioplasty-results of a randomized trial of a novel homeostatic device. J Am Coll Cardiol 1995;25:1685-92
DOI
ScienceOn
|
5 |
Abando A, Hood D, Weaver F, et al. The use of Angioseal device for femoral artery closure. J Vasc Surg 2004;40:287-90
DOI
ScienceOn
|
6 |
Ernst SM, Tjonjoegin RM, Schrader R, et al. Immediet sealing of arterial puncture sites after cardiac catheterization and coronary angioplasty using a biodegradable collagen plug results of an international registry. J Am Coll Cardiol 1993;21:851-5
DOI
ScienceOn
|
7 |
Carey D, Martin JR, Moore CA, et al. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 2001;52:3-7
DOI
ScienceOn
|
8 |
Baims DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: result of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-9
DOI
ScienceOn
|